Ignite Creation Date:
2024-05-06 @ 8:58 AM
Last Modification Date:
2024-10-26 @ 12:07 PM
Study NCT ID:
NCT02860260
Status:
COMPLETED
Last Update Posted:
2016-08-09
First Post:
2016-08-01
Brief Title:
Kinetics of Plasma and Serum Levels of Brain-Derived Neurotrophic Factor BDNF in Patients With Ischemic Stroke
Sponsor:
Centre Hospitalier Universitaire Dijon
Organization:
Centre Hospitalier Universitaire Dijon
Study Overview
Official Title:
Kinetics of Plasma and Serum Levels of Brain-Derived Neurotrophic Factor BDNF in Patients With Ischemic Stroke Effect of Intravenous Fibrinolysis With Rt-PA
Status:
COMPLETED
Status Verified Date:
2016-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
BDNF
Brief Summary:
The aim of this study is to show for the first time that treatment with intravenous fibrinolysis using rt-PA in patients with recent ischemic stroke is accompanied by increases in circulating levels of BDNF which may reflect an increase in BDNF synthesis in the brain
The analysis of the recovery of functional and cognitive abilities as well as mood at 3 months will allow us to study the impact of BDNF on these parameters Thus depending on the results obtained circulating BDNF could serve as an early marker of these
The analysis of the recovery of functional and cognitive abilities as well as mood at 3 months will allow us to study the impact of BDNF on these parameters Thus depending on the results obtained circulating BDNF could serve as an early marker of these
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None